Bridget Kathleen Biggs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bridget Kathleen Biggs has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Stephen P. H. Whiteside
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, USA
6 shared publications Deanna R. Hofschulte
Mayo Clinic
5 shared publications- Lilianne M. Gloe
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, USA
4 shared publications Seema Kumar
Division of Pediatric Endocrinology and Metabolism, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA
4 shared publications- Seema Kumar
Division of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine Mayo Clinic Rochester Minnesota USA
4 shared publications - Jocelyn Lebow
Department of Psychiatry and Psychology, Mayo Clinic School of Medicine, Rochester, USA
3 shared publications
Latest Publications
- 22 September 2026
- Published by Springer Nature in Journal of Child and Family Studies
- Vol. 35 (10) , 2173-2187
Applying the IDEAS Framework to the Development of a Digital Health Intervention to Support Child Mental Health Care
- 22 September 2026
- Published by Springer Nature in Journal of Child and Family Studies
- Vol. 35 (10) , 2173-2187
Applying the IDEAS Framework to the Development of a Digital Health Intervention to Support Child Mental Health Care
- 13 August 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Clinical, Genetic, and Endocrine Features of Bardet‐Biedl Syndrome in a Pediatric and Adult Cohort
Bardet‐Biedl syndrome (BBS) is a rare autosomal recessive disorder characterized by clinical and genetic heterogeneity. Data on the prevalence of clinical manifestations and comorbidities in BBS, particularly in pediatric patients, are limited. This study aimed to assess the prevalence and various manifestations of endocrine and other clinical comorbidities among pediatric and adult patients with BBS. This retrospective chart review included pediatric and adult patients with BBS evaluated at an academic tertiary care center in the United States between 2000 and 2024. The study included 31 patients (7 children and 24 adults) with seven identified pathogenic variants associated with BBS. The most common genetic etiology was biallelic variants in BBS1 (36%). Obesity was diagnosed in 86% of children and 100% of adults. No children had diabetes or prediabetes, whereas 46% of adults were affected. Dyslipidemia was identified in 29% of children and 46% of adults. No thyroid abnormalities were identified in children, whereas 25% of adults were affected. Retinal dystrophy was present in 71% of children and 96% of adults. Polydactyly was observed in 100% of children and 75% of adults. Chronic kidney disease was present in 29% of children and 63% of adults. This study highlights the clinical heterogeneity and substantial multisystem burden of BBS across pediatric and adult patients. The greater prevalence of diabetes/prediabetes, dyslipidemia, thyroid abnormalities, chronic kidney disease, and visual impairment among adults suggests that these complications may emerge or progress over time. Early recognition, proactive longitudinal surveillance, and comprehensive multidisciplinary care are essential to optimize management across the lifespan.
- 13 August 2026
- Published by Wiley in American Journal of Medical Genetics Part A
Clinical, Genetic, and Endocrine Features of Bardet‐Biedl Syndrome in a Pediatric and Adult Cohort
Bardet‐Biedl syndrome (BBS) is a rare autosomal recessive disorder characterized by clinical and genetic heterogeneity. Data on the prevalence of clinical manifestations and comorbidities in BBS, particularly in pediatric patients, are limited. This study aimed to assess the prevalence and various manifestations of endocrine and other clinical comorbidities among pediatric and adult patients with BBS. This retrospective chart review included pediatric and adult patients with BBS evaluated at an academic tertiary care center in the United States between 2000 and 2024. The study included 31 patients (7 children and 24 adults) with seven identified pathogenic variants associated with BBS. The most common genetic etiology was biallelic variants in BBS1 (36%). Obesity was diagnosed in 86% of children and 100% of adults. No children had diabetes or prediabetes, whereas 46% of adults were affected. Dyslipidemia was identified in 29% of children and 46% of adults. No thyroid abnormalities were identified in children, whereas 25% of adults were affected. Retinal dystrophy was present in 71% of children and 96% of adults. Polydactyly was observed in 100% of children and 75% of adults. Chronic kidney disease was present in 29% of children and 63% of adults. This study highlights the clinical heterogeneity and substantial multisystem burden of BBS across pediatric and adult patients. The greater prevalence of diabetes/prediabetes, dyslipidemia, thyroid abnormalities, chronic kidney disease, and visual impairment among adults suggests that these complications may emerge or progress over time. Early recognition, proactive longitudinal surveillance, and comprehensive multidisciplinary care are essential to optimize management across the lifespan.
- 29 July 2026
- Published by Taylor & Francis in Child & Family Behavior Therapy
- p. 1-17
Mental Health Service Use After Randomized Control Trial Comparing Parent-Coached Exposure Therapy and Cognitive Behavioral Therapy for Pediatric Anxiety Disorders: A Chart Review
Cognitive behavioral therapy (CBT) is the most recommended and empirically-supported intervention for childhood anxiety disorders (CADs; herein defined as separation anxiety disorder, social anxiet...
- 29 July 2026
- Published by Taylor & Francis in Child & Family Behavior Therapy
- p. 1-17
Mental Health Service Use After Randomized Control Trial Comparing Parent-Coached Exposure Therapy and Cognitive Behavioral Therapy for Pediatric Anxiety Disorders: A Chart Review
Cognitive behavioral therapy (CBT) is the most recommended and empirically-supported intervention for childhood anxiety disorders (CADs; herein defined as separation anxiety disorder, social anxiet...
- 10 April 2026
- Published by Wiley in Journal of Clinical Psychology
- Vol. 82 (8) , 1142-1153
Differentiating the Course of Symptom Improvement Between Two Treatments for Childhood Anxiety Disorders
Objectives: Cognitive behavioral therapy (CBT) is the most researched treatment for childhood anxiety disorders (CADs). Improving outcomes and efficiency of CBT will require identifying and optimizing the most efficacious therapeutic components. Towards this end, a recent randomized controlled trial (RCT) found that Parent Coached Exposure Therapy (PCET) led to greater symptom improvement in less time than traditional CBT. To better understand and maximize these advantages, the current study explores the timing and course of symptom improvement in these two treatments for CADs, CBT, and PCET. Methods: In this secondary analysis of data from the RCT, 56 youth aged 7−17 years (73.2% female) and a parent provided weekly ratings of anxiety symptom severity. Results: The mean anxiety severity ratings decreased significantly in both conditions, but a significant condition by time interaction suggested that the pace of change differed between treatment for parent report, F (6.2, 335) = 2.96, p = 0.007. A series of post‐hoc comparisons indicated that the ratings became significantly lower in the PCET group beginning in session 3 (effect size = 0.77) through post‐treatment assessment. In addition, within each treatment condition the largest change in severity ratings occurred after the introduction of exposure, effect sizes of 0.68 for PCET and 0.56 for CBT. The child severity ratings followed a similar pattern but did not reach statistical significance. Discussion: The implications of these exploratory and hypothesis‐generating findings for designing treatment protocols to deliver exposure in a manner to maximize the amount, and pace, of improvement are discussed.
- 10 April 2026
- Published by Wiley in Journal of Clinical Psychology
- Vol. 82 (8) , 1142-1153
Differentiating the Course of Symptom Improvement Between Two Treatments for Childhood Anxiety Disorders
Objectives: Cognitive behavioral therapy (CBT) is the most researched treatment for childhood anxiety disorders (CADs). Improving outcomes and efficiency of CBT will require identifying and optimizing the most efficacious therapeutic components. Towards this end, a recent randomized controlled trial (RCT) found that Parent Coached Exposure Therapy (PCET) led to greater symptom improvement in less time than traditional CBT. To better understand and maximize these advantages, the current study explores the timing and course of symptom improvement in these two treatments for CADs, CBT, and PCET. Methods: In this secondary analysis of data from the RCT, 56 youth aged 7−17 years (73.2% female) and a parent provided weekly ratings of anxiety symptom severity. Results: The mean anxiety severity ratings decreased significantly in both conditions, but a significant condition by time interaction suggested that the pace of change differed between treatment for parent report, F (6.2, 335) = 2.96, p = 0.007. A series of post‐hoc comparisons indicated that the ratings became significantly lower in the PCET group beginning in session 3 (effect size = 0.77) through post‐treatment assessment. In addition, within each treatment condition the largest change in severity ratings occurred after the introduction of exposure, effect sizes of 0.68 for PCET and 0.56 for CBT. The child severity ratings followed a similar pattern but did not reach statistical significance. Discussion: The implications of these exploratory and hypothesis‐generating findings for designing treatment protocols to deliver exposure in a manner to maximize the amount, and pace, of improvement are discussed.
- 20 August 2025
- Published by SAGE Publications in Childhood Obesity
- Vol. 21 (8) , 682-687
Assessing Alignment of Referrals with Guidelines for the Treatment of Children with Obesity
It is unknown how many children with obesity are offered treatments aligned with clinical practice guidelines. This study examined electronic medical record data from a Midwest, USA, health system to quantify referrals to obesity treatment among patients 2–17 years old with obesity presenting for well-child visits in 2022 and/or 2023. Mixed-effects logistic regression models tested associations of referral placement with child characteristics, the Area Deprivation Index, and distance to specialty care. Of 14,893 patients, 591 (4.0%) received a referral. Referrals were associated with severe obesity ( p < 0.001), older age ( p < 0.001), proximity to specialty care ( p < 0.001), number of well-visits ( p ≤ 0.001), and identification with a minoritized race or ethnicity ( p < 0.05–0.001). Findings indicate a large gap from the current state of referrals to alignment with practice guidelines for pediatric obesity. Furthermore, research needs to explore and address barriers to referrals and treatment access.
- 20 August 2025
- Published by SAGE Publications in Childhood Obesity
- Vol. 21 (8) , 682-687
Assessing Alignment of Referrals with Guidelines for the Treatment of Children with Obesity
It is unknown how many children with obesity are offered treatments aligned with clinical practice guidelines. This study examined electronic medical record data from a Midwest, USA, health system to quantify referrals to obesity treatment among patients 2–17 years old with obesity presenting for well-child visits in 2022 and/or 2023. Mixed-effects logistic regression models tested associations of referral placement with child characteristics, the Area Deprivation Index, and distance to specialty care. Of 14,893 patients, 591 (4.0%) received a referral. Referrals were associated with severe obesity ( p < 0.001), older age ( p < 0.001), proximity to specialty care ( p < 0.001), number of well-visits ( p ≤ 0.001), and identification with a minoritized race or ethnicity ( p < 0.05–0.001). Findings indicate a large gap from the current state of referrals to alignment with practice guidelines for pediatric obesity. Furthermore, research needs to explore and address barriers to referrals and treatment access.
- 22 July 2025
- Published by Elsevier in Behavior Therapy
- Vol. 57 (1) , 103-117
Effects of Parent-Coached Exposure Therapy Versus CBT on Avoidance, Impairment, and Remission in Childhood Anxiety
- 22 July 2025
- Published by Elsevier in Behavior Therapy
- Vol. 57 (1) , 103-117
Effects of Parent-Coached Exposure Therapy Versus CBT on Avoidance, Impairment, and Remission in Childhood Anxiety
- 12 February 2025
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 81, e57-e64
Pediatric obesity management practices and needs: A survey of primary care providers
- 12 February 2025
- Published by Elsevier in Journal of Pediatric Nursing
- Vol. 81, e57-e64
Pediatric obesity management practices and needs: A survey of primary care providers
- 23 January 2025
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 110, 102974
A comparison of virtual reality and verbal imaginal exposure for childhood anxiety disorders
- 23 January 2025
- Published by Elsevier in Journal of Anxiety Disorders
- Vol. 110, 102974
A comparison of virtual reality and verbal imaginal exposure for childhood anxiety disorders